Neurodermatitis, also known as atopic eczema, is chronic and verycommon skin inflammation. This usually develops in infants and children. However, this type of skin problem can persist and even occurs in teenagers and adults. The treatment of this skin disease is carried out through topical care and depending on the specific problem. In contrast, moisturizers, antiseptics or ointments based on corticosteroids are usually used. However, a recent study promises to revolutionize the treatment of various skin infections involving bacteria.
Potential therapy for atopic eczema and other skin problems
The important discovery was made by researchers at the University of California San Diego School of Medicine in the US. They were able to identify a universal strain of bacteria found on a healthy human skin surface. These bacteria can relieve symptoms of atopic dermatitis by reducing the inflammation and itching they cause. Scientists set out to examine more than 8,000 isolates of staphylococci from healthy skin. These were from subjects without eczema. The method allowed researchers to identify strains that can inhibit the development of eczema. This is a specific type of bacteria derived from Staphylococcus hominis A9.
Initially, tests were carried out on laboratory mice. This was required before a Phase 1 clinical trial could be conducted in 54 volunteers with atopic eczema. The results showed a sharp decrease in Staphylococcal aureus, the pathogenic bacteria responsible for worsening the skin disease. The research team also saw an improvement in symptoms of itching and inflammation of the skin. The scientists therefore confirm an improvement in the condition of the participants who received bacterial treatment. The test subjects even reported no side effects. The authorsthis studyadd that future analyzes will determine the potential use of this treatment over a long period of time. This approach would reduce the severity of atopic dermatitis and significantly improve patients' quality of life.
